Skip to main content
PMC home page
Gut logoLink to Gut
. 1999 Oct;45(4):613–617. doi: 10.1136/gut.45.4.613

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus

C Chu 1, C Yeh 1, Y Liaw 1
PMCID: PMC1727691  PMID: 10486374

Abstract

BACKGROUND/AIMS—The role of hepatitis C virus (HCV) in fulminant hepatitis remains controversial. This study was conducted to investigate the risk of fulminant hepatitis C in relation to HCV genotypes and concurrent infection of other viruses.
PATIENTS—109 HCV RNA positive patients from 334 consecutive cases hospitalised to a medical centre in northern Taiwan for overt acute viral hepatitis were prospectively evaluated.
METHODS—HCV RNA was detected by a combined reverse transcription-polymerase chain reaction assay. HCV genotypes were analysed using a genotype specific probe based assay in the 5' untranslated region.
RESULTS—39 patients tested positive for hepatitis B surface antigen but negative for IgM antibody to hepatitis B core antigen, indicating concurrent chronic hepatitis B virus (HBV) infection. Twelve patients were hepatitis G virus (HGV) RNA positive. Genotyping of HCV disclosed 1b in 93, 1b mixed with 2a/2c or 1b mixed with 2b in 11, and not classified in five. Serum titres of HCV RNA were <105 copies/ml in 77, 105-107 copies/ml in 25, and >107 copies/ml in seven. Eleven patients (10.1%) had fulminant hepatitis as a complication. Development of fulminant hepatitis did not correlate with age and gender of the patients, concurrent HGV infection, HCV genotypes, or serum titre of HCV RNA. However, the incidence (95% confidence interval) of fulminant hepatitis in patients with underlying chronic HBV infection was 23.1% (9.9 to 36.3%), which is significantly higher than in those without (2.9% (−1.0 to 6.8%)). In 39 patients with concurrent chronic HBV infection, the clinical and virological characteristics showed no significant difference between those with fulminant hepatitis and those without.
CONCLUSIONS—Acute hepatitis C in patients with concurrent chronic HBV infection is associated with a substantial risk of fulminant hepatitis.


Keywords: acute hepatitis C; fulminant hepatitis; hepatitis B virus; hepatitis C virus; hepatitis G virus

Full Text

The Full Text of this article is available as a PDF (82.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992 Dec 31;327(27):1899–1905. doi: 10.1056/NEJM199212313272702. [DOI] [PubMed] [Google Scholar]
  2. Bernuau J., Rueff B., Benhamou J. P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis. 1986 May;6(2):97–106. doi: 10.1055/s-2008-1040593. [DOI] [PubMed] [Google Scholar]
  3. Chu C. M., Karayiannis P., Fowler M. J., Monjardino J., Liaw Y. F., Thomas H. C. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology. 1985 May-Jun;5(3):431–434. doi: 10.1002/hep.1840050315. [DOI] [PubMed] [Google Scholar]
  4. Chu C. M., Liaw Y. F. Peripheral T-cell subsets in asymptomatic hepatitis B-virus carriers. Cell Immunol. 1986 Apr 1;98(2):533–537. doi: 10.1016/0008-8749(86)90312-6. [DOI] [PubMed] [Google Scholar]
  5. Chu C. M., Liaw Y. F. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state. Infection. 1990 Jul-Aug;18(4):200–203. doi: 10.1007/BF01643385. [DOI] [PubMed] [Google Scholar]
  6. Chu C. M., Liaw Y. F., Yang C. Y., Sheen I. S. Diagnosis of acute type B hepatitis by a solid phase u-antibody capture radioimmunoassay for IgM class antibody to hepatitis B core antigen: a diagnostic proposal based on a prospective study. Liver. 1987 Jun;7(3):182–187. doi: 10.1111/j.1600-0676.1987.tb00340.x. [DOI] [PubMed] [Google Scholar]
  7. Chu C. M., Sheen I. S., Liaw Y. F. The aetiology of acute hepatitis in Taiwan: acute hepatitis superimposed on HBsAg carrier state as the main aetiology of acute hepatitis in areas with high HBsAg carrier rate. Infection. 1988 Jul-Aug;16(4):233–237. doi: 10.1007/BF01650760. [DOI] [PubMed] [Google Scholar]
  8. Chu C. M., Sheen I. S., Liaw Y. F. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology. 1994 Jul;107(1):189–195. doi: 10.1016/0016-5085(94)90076-0. [DOI] [PubMed] [Google Scholar]
  9. Dawson G. J., Schlauder G. G., Pilot-Matias T. J., Thiele D., Leary T. P., Murphy P., Rosenblatt J. E., Simons J. N., Martinson F. E., Gutierrez R. A. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol. 1996 Sep;50(1):97–103. doi: 10.1002/(SICI)1096-9071(199609)50:1<97::AID-JMV16>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  10. Dienstag J. L. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology. 1983 Aug;85(2):439–462. [PubMed] [Google Scholar]
  11. Féray C., Gigou M., Samuel D., Reyes G., Bernuau J., Reynes M., Bismuth H., Bréchot C. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology. 1993 Feb;104(2):549–555. doi: 10.1016/0016-5085(93)90425-c. [DOI] [PubMed] [Google Scholar]
  12. Ikeda T., Lever A. M., Thomas H. C. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Hepatology. 1986 Sep-Oct;6(5):962–965. doi: 10.1002/hep.1840060525. [DOI] [PubMed] [Google Scholar]
  13. Kao J. H., Chen P. J., Chen W., Hsiang S. C., Lai M. Y., Chen D. S. Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome. J Med Virol. 1997 Apr;51(4):284–289. [PubMed] [Google Scholar]
  14. Keeffe E. B. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol. 1995 Feb;90(2):201–205. [PubMed] [Google Scholar]
  15. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  16. Liang T. J., Jeffers L., Reddy R. K., Silva M. O., Cheinquer H., Findor A., De Medina M., Yarbough P. O., Reyes G. R., Schiff E. R. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology. 1993 Feb;104(2):556–562. doi: 10.1016/0016-5085(93)90426-d. [DOI] [PubMed] [Google Scholar]
  17. O'Grady J. G., Schalm S. W., Williams R. Acute liver failure: redefining the syndromes. Lancet. 1993 Jul 31;342(8866):273–275. doi: 10.1016/0140-6736(93)91818-7. [DOI] [PubMed] [Google Scholar]
  18. Papaevangelou G., Tassopoulos N., Roumeliotou-Karayannis A., Richardson C. Etiology of fulminant viral hepatitis in Greece. Hepatology. 1984 May-Jun;4(3):369–372. doi: 10.1002/hep.1840040304. [DOI] [PubMed] [Google Scholar]
  19. Sallie R., Silva A. E., Purdy M., Smith H., McCaustland K., Tibbs C., Portmann B., Eddleston A., Bradley D., Williams R. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol. 1994 May;20(5):580–588. doi: 10.1016/s0168-8278(05)80343-5. [DOI] [PubMed] [Google Scholar]
  20. Takada N., Takase S., Takada A., Date T. Differences in the hepatitis C virus genotypes in different countries. J Hepatol. 1993 Mar;17(3):277–283. doi: 10.1016/s0168-8278(05)80205-3. [DOI] [PubMed] [Google Scholar]
  21. Theilmann L., Solbach C., Toex U., Müller H. M., Pfaff E., Otto G., Goeser T. Role of hepatitis C virus infection in German patients with fulminant and subacute hepatic failure. Eur J Clin Invest. 1992 Aug;22(8):569–571. doi: 10.1111/j.1365-2362.1992.tb01507.x. [DOI] [PubMed] [Google Scholar]
  22. Trey C., Davidson C. S. The management of fulminant hepatic failure. Prog Liver Dis. 1970;3:282–298. [PubMed] [Google Scholar]
  23. Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G., Ferraro T., Concia E. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998 Jan 29;338(5):286–290. doi: 10.1056/NEJM199801293380503. [DOI] [PubMed] [Google Scholar]
  24. Wright T. L., Mamish D., Combs C., Kim M., Donegan E., Ferrell L., Lake J., Roberts J., Ascher N. L. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 1992 Apr 18;339(8799):952–955. doi: 10.1016/0140-6736(92)91530-l. [DOI] [PubMed] [Google Scholar]
  25. Wu J. S., Chen C. H., Chiang Y. H., Lee Y. C., Lee M. H., Ko Y. C., Hu H. T. Hepatitis A virus infection in Taiwan. Taiwan Yi Xue Hui Za Zhi. 1980 Aug;79(8):694–699. [PubMed] [Google Scholar]
  26. Yanagi M., Kaneko S., Unoura M., Murakami S., Kobayashi K., Sugihara J., Ohnishi H., Muto Y. Hepatitis C virus in fulminant hepatic failure. N Engl J Med. 1991 Jun 27;324(26):1895–1896. doi: 10.1056/NEJM199106273242615. [DOI] [PubMed] [Google Scholar]
  27. Yeh C. T., Shyu W. C., Sheen I. S., Chu C. M., Liaw Y. F. Quantitative assessment of hepatitis C virus RNA by polymerase chain reaction and a digoxigenin detection system: comparison with branched DNA assay. J Virol Methods. 1997 May;65(2):219–226. doi: 10.1016/s0166-0934(97)02187-3. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES